Promega Corporation

High-Throughput Automation of Multiplexed Cell-Based Assays for Viability and Cytotoxicity

  • Share
  • Print
  • Email
  • Download PDF
  • Article
  • Comments & Ratings

Abstract

Here we demonstrate the use of the MultiTox Family of cytotoxicity assays in 1,536-well screening experiments and in multiplex with caspase assays in 384-well formats.

Cell Notes 20, 26–29.

Tracy Worzella1, Michael Busch2 and Andrew Niles1

1Promega Corporation, 2CYBIO, AG

Publication Date: 2008

Download Article (913 KB)

Prefer a different language?

Your country is set to Korea, Republic Of. Your language is set to 한국어. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.